PLCG2 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation: Our study reported the first case of APLAID with gangrenous pyoderma and concomitant high IgE carrying a novel PLCG2 mutation, which may expand the clinical phenotype and genotype of APLAID.